Abstract
Two research teams have taken an important first step towards exploiting human embryonic stem (ES) cells for the treatment of neurological diseases. The teams, led by Su-Chun Zhang (University of Wisconsin, Madison, WI, USA) and Benjamin Reubinoff (Hadassah University Hospital, Jerusalem, Israel), independently report the in-vitro differentiation of ES cells into near-pure cultures of neural precursor cells (Nat Biotechnol 2001; 19: 1129–33 and 1134–40). Both groups also report successful transplantation of precursor cells into neonatal mouse brains.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
